The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study

The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study

Abstract Background Initial studies suggest pharmaceutical grade cannabidiol (CBD) can reduce the frequency of convulsive seizures and lead to improvements in quality of life in children affected by epileptic encephalopathies. With limited access to pharmaceutical CBD, Cannabis extracts in oil are b...

Full description

Bibliographic Details
Main Authors: Darren Reithmeier, Richard Tang-Wai, Blair Seifert, Andrew W. Lyon, Jane Alcorn, Bryan Acton, Scott Corley, Erin Prosser-Loose, Darrell D. Mousseau, Hyun J. Lim, Jose Tellez-Zenteno, Linda Huh, Edward Leung, Lionel Carmant, Richard J. Huntsman
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Pediatrics
Subjects:
Cannabis
Cannabidiol
Pediatric epilepsy
CanniMed®
Online Access:http://link.springer.com/article/10.1186/s12887-018-1191-y

Internet

http://link.springer.com/article/10.1186/s12887-018-1191-y

Similar Items